Updates in Surgery

, Volume 69, Issue 2, pp 205–209 | Cite as

Surgical approach to level VI in papillary thyroid carcinoma: an overview

  • Carmela De Crea
  • Marco Raffaelli
  • Luca Sessa
  • Celestino Pio Lombardi
  • Rocco Bellantone
Review Article
Part of the following topical collections:
  1. Endocrine surgery


One of the most controversial issues in the treatment of thyroid cancer is the management of the central neck nodes in patients with papillary thyroid carcinoma (PTC). Lymph node involvement is common in patients with PTC and it may negatively affect recurrence rate and, probably, survival. Although therapeutic compartment-oriented central neck dissection is the standard treatment for patients with clinical nodal involvement (cN1) PTC, the role and the extension for elective or prophylactic central neck dissection (PCND) in patients with clinically node negative (cN0) neoplasms remains controversial. In recent years, in order to decrease the risk of postoperative complications related to PCND, unilateral central neck dissection has emerged as an alternative approach to bilateral central neck dissection.


Papillary thyroid carcinoma Central neck dissection Prophylactic central neck dissection Video-assisted central neck dissection Reoperative central neck dissection 


Author contributions

Study conception and design: CPL, MR, and RB. Acquisition of the data: CC and LS. Analysis and interpretation of data: CPL, MR, CC, and LS. Drafting of manuscript: CPL, MR, CC, and LS. Critical revision of manuscript: RB, CPL, and MR.

Compliance with ethical standards

Conflict of interest

The authors declare that they have no competing interests.

Research involving human participants and/or animals

The present manuscript is compliant with ethical standard. This study does not involve any kind of animal related contacts or experiments by any of the listed authors.

Informed consent

All the patients included gave their informed consent.


  1. 1.
    McLeod DS, Sawka AM, Cooper DS (2013) Controversies in primary treatment of low-risk papillary thyroid cancer. Lancet 381:1046–1057CrossRefPubMedGoogle Scholar
  2. 2.
    Shan CX, Zhang W, Jiang DZ, Zheng XM, Liu S, Qui M (2012) Routine central neck dissection in differentiated thyroid carcinoma: a systematic review and meta-analysis. Laryngoscope 122:797–804CrossRefPubMedGoogle Scholar
  3. 3.
    White ML, Gauger PG, Doherty GM (2007) Central lymph node dissection in differentiated thyroid cancer. World J Surg 31:895–904CrossRefPubMedGoogle Scholar
  4. 4.
    Sippel RS, Chen H (2009) Controversies in the surgical management of newly diagnosed and recurrent/residual thyroid cancer. Thyroid 19:1373–1380CrossRefPubMedGoogle Scholar
  5. 5.
    Lang BH, Ng SH, Lau L, Cowling B, Wong KP, Whan KY (2013) A systematic review and meta-analysis of prophylactic central neck dissection on short-term locoregional recurrence in papillary thyroid carcinoma after total thyroidectomy. Thyroid 23:1087–1098CrossRefPubMedGoogle Scholar
  6. 6.
    Liang J, Li Z, Fang F, Yu T, Li S (2017) Is prophylactic central neck dissection necessary for cN0 differentiated thyroid cancer patients at initial treatment? A meta-analysis of the literature. Acta Otorhinolaryngol Ital 37:1–8PubMedPubMedCentralGoogle Scholar
  7. 7.
    Carty SE, Cooper DS, Doherty GM et al (2009) Consensus statement on the terminology and classification of central neck dissection for thyroid cancer. Thyroid 19:1153–1158CrossRefPubMedGoogle Scholar
  8. 8.
    Haugen BR, Alexander EK, Bible KC et al (2016) 2015 American Thyroid Association Management Guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer. Thyroid 26:1–133CrossRefPubMedPubMedCentralGoogle Scholar
  9. 9.
    Perros P, Boelaert K, Colley S et al (2014) British Thyroid Association. Guidelines for the management of thyroid cancer. Clin Endocrinol (Oxf) 81(Suppl 1):1–122CrossRefGoogle Scholar
  10. 10.
    Sancho JJ, Lennard TW, Paunovic I et al (2014) Prophylactic central neck dissection in papillary thyroid cancer: a consensus report of the European Society of Endocrine Surgeons (ESES). Langenbecks Arch Surg 399:155–163CrossRefPubMedGoogle Scholar
  11. 11.
    Barczynski M, Konturek A, Stopa M, Nowak W (2013) Prophylactic central neck dissection for papillary thyroid cancer. Br J Surg 100:410–418CrossRefPubMedGoogle Scholar
  12. 12.
    Giordano D, Valcavi R, Thompson GB, Pedroni C, Renna L, Gradoni P et al (2012) Complications of central neck dissection in patients with papillary thyroid carcinoma: results of a study on 1087 patients and review of the literature. Thyroid 22:911–917CrossRefPubMedGoogle Scholar
  13. 13.
    Sadowski BM, Snyder SK, Lairmore TC (2009) Routine bilateral central lymph node clearance for papillary thyroid cancer. Surgery 146:696–705CrossRefPubMedGoogle Scholar
  14. 14.
    Shaha AR (2009) Prophylactic central compartment dissection in thyroid cancer: a new avenue of debate. Surgery 146:1224–1227CrossRefPubMedGoogle Scholar
  15. 15.
    Hughes DT, White ML, Miller BS, Gauger PG, Burney RE, Doherty GM (2010) Influence of prophylactic central lymph node dissection on postoperative thyroglobulin levels and radioiodine treatment in papillary thyroid cancer. Surgery 148:1100–1106CrossRefPubMedGoogle Scholar
  16. 16.
    Cisco RM, Shen WT, Gosnell JE (2012) Extent of surgery for papillary thyroid cancer: preoperative imaging and role of prophylactic and therapeutic neck dissection. Curr Treat Options Oncol 13:1–10CrossRefPubMedGoogle Scholar
  17. 17.
    Carling T, Long WD III, Udelsman R (2010) Controversy surrounding the role for routine central lymph node dissection for differentiated thyroid cancer. Curr Opin Oncol 22:30–34CrossRefPubMedGoogle Scholar
  18. 18.
    Moo TS, Umunna B, Kato M et al (2009) Ipsilateral versus bilateral central neck lymph node dissection in papillary thyroid carcinoma. Ann Surg 250:403–408PubMedGoogle Scholar
  19. 19.
    Chae BJ, Jung CK, Lim DJ, Song BJ, Kim JS, Jung SS, Bae JS (2011) Performing contralateral central lymph node dissection in papillary thyroid carcinoma: a decision approach. Thyroid 21:873–877CrossRefPubMedGoogle Scholar
  20. 20.
    Raffaelli M, De Crea C, Sessa L, Giustacchini P, Revelli L, Bellantone C, Lombardi CP (2012) Prospective evaluation of total thyroidectomy versus ipsilateral versus bilateral central neck dissection in patients with clinically node negative papillary thyroid carcinoma. Surgery 152:957–964CrossRefPubMedGoogle Scholar
  21. 21.
    Raffaelli M, De Crea C, Sessa L, Giustacchini P, Bellantone R, Lombardi CP (2013) Can intraoperative frozen section influence the extension of central neck dissection in cN0 papillary thyroid carcinoma? Langenbecks Arch Surg 398:383–388CrossRefPubMedGoogle Scholar
  22. 22.
    Raffaelli M, De Crea C, Sessa L et al (2015) Ipsilateral central neck dissection plus frozen section examination versus prophylactic bilateral central neck dissection in cN0 papillary thyroid carcinoma. Ann Surg Oncol 22:2302–2308CrossRefPubMedGoogle Scholar
  23. 23.
    Viola D, Materazzi G, Valerio L et al (2015) Prophylactic central compartment lymph node dissection in papillary thyroid carcinoma: clinical implications derived from the first prospective randomized controlled single institution study. J Clin Endocrinol Metab 100:1316–1324CrossRefPubMedGoogle Scholar
  24. 24.
    Calò PG, Conzo G, Raffaelli M et al (2017) Total thyroidectomy alone versus ipsilateral versus bilateral prophylactic central neck dissection in clinically node-negative differentiated thyroid carcinoma. A retrospective multicenter study. Eur J Surg Oncol 43:126–132CrossRefPubMedGoogle Scholar
  25. 25.
    Son YI, Jeong HS, Baek CH et al (2008) Extent of prophylactic lymph node dissection in the central neck area of the patients with papillary thyroid carcinoma: comparison of limited versus comprehensive lymph node dissection in a 2-year safety study. Ann Surg Oncol 15:2020–2026CrossRefPubMedGoogle Scholar
  26. 26.
    Koo BS, Choi EC, Yoon YH, Kim DH, Kim EH, Lim YC (2009) Predictive factors for ipsilateral or contralateral central lymph node metastasis in unilateral papillary thyroid carcinoma. Ann Surg 249:840–844CrossRefPubMedGoogle Scholar
  27. 27.
    Bellantone R, Lombardi CP, Raffaelli M et al (2003) Video-assisted thyroidectomy for papillary thyroid carcinoma. Surg Endosc 17:1604–1608CrossRefPubMedGoogle Scholar
  28. 28.
    Lombardi CP, Raffaelli M, de Crea C et al (2007) Report on 8 years of experience with video-assisted thyroidectomy for papillary thyroid carcinoma. Surgery 142:944–951CrossRefPubMedGoogle Scholar
  29. 29.
    Miccoli P, Elisei R, Materazzi G et al (2002) Minimally invasive video-assisted thyroidectomy for papillary carcinoma: a prospective study of its completeness. Surgery 132:1070–1074CrossRefPubMedGoogle Scholar
  30. 30.
    Bellantone R, Lombardi CP, Raffaelli M et al (2002) Central neck lymph node removal during minimally invasive video-assisted thyroidectomy for thyroid carcinoma: a feasible and safe procedure. J Laparoendosc Adv Surg Tech A 12:181–185CrossRefPubMedGoogle Scholar
  31. 31.
    Lombardi CP, Raffaelli M, De Crea C et al (2012) Video-assisted versus conventional total thyroidectomy and central compartment neck dissection for papillary thyroid carcinoma. World J Surg 36:1225–1230CrossRefPubMedGoogle Scholar
  32. 32.
    Podnos YD, Smith D, Wagman LD, Ellenhorn JD (2005) The implication of lymph node metastasis on survival in patients with well-differentiated thyroid cancer. Am Surg 71:731–734PubMedGoogle Scholar
  33. 33.
    Leboulleux S, Rubino C, Baudin E et al (2005) Prognostic factors for persistent or recurrent disease of papillary thyroid carcinoma with neck lymph node metastases and/or tumor extension beyond the thyroid capsule at initial diagnosis. J Clin Endocrinol Metab 90:5723–5729CrossRefPubMedGoogle Scholar
  34. 34.
    Sugitani I, Kasai N, Fujimoto Y, Yanagisawa A (2004) A novel classification system for patients with PTC: addition of the new variables of large (3 cm or greater) nodal metastases and reclassification during the follow-up period. Surgery 135:139–148CrossRefPubMedGoogle Scholar
  35. 35.
    Adam MA, Pura J, Goffredo P et al (2015) Presence and number of lymph node metastases are associated with compromised survival for patients younger than age 45 years with papillary thyroid cancer. J Clin Oncol 33:2370–2375CrossRefPubMedGoogle Scholar
  36. 36.
    Randolph GW, Duh QY, Heller KS et al (2012) The prognostic significance of nodal metastases from papillary thyroid carcinoma can be stratified based on the size and number of metastatic lymph nodes, as well as the presence of extranodal extension. Thyroid 22:1144–1152CrossRefPubMedGoogle Scholar
  37. 37.
    Carling T, Carty SE, Ciarleglio MM, Cooper DS, Doherty GM, Kim LT et al (2012) American Thyroid Association design and feasibility of a prospective randomized controlled trial of prophylactic central lymph node dissection for papillary thyroid carcinoma. Thyroid 22:237–244CrossRefPubMedGoogle Scholar
  38. 38.
    Shen WT, Ogawa L, Ruan D et al (2010) Central neck lymph node dissection for papillary thyroid cancer: the reliability of surgeon judgment in predicting which patients will benefit. Surgery 148:398–403CrossRefPubMedGoogle Scholar
  39. 39.
    Mazzaferri EL, Doherty GM, Steward DL (2009) The pros and cons of prophylactic central compartment lymph node dissection for papillary thyroid carcinoma. Thyroid 19:683–689CrossRefPubMedGoogle Scholar
  40. 40.
    Zuniga S, Sanabria A (2009) Prophylactic central neck dissection in stage N0 papillary thyroid carcinoma. Arch Otolaryngol Head Neck Surg 135:1087–1091CrossRefPubMedGoogle Scholar
  41. 41.
    Blanchard C, Brient C, Volteau C et al (2013) Factors predictive of lymph node metastasis in the follicular variant of papillary thyroid carcinoma. Br J Surg 100:1312–1317CrossRefPubMedGoogle Scholar
  42. 42.
    Cranshaw IM, Carnaille B (2008) Micrometastases in thyroid cancer. An important finding? Surg Oncol 17:253–258CrossRefPubMedGoogle Scholar

Copyright information

© Italian Society of Surgery (SIC) 2017

Authors and Affiliations

  1. 1.Istituto di Semeiotica Chirurgica, U.O. Chirurgia Endocrina e MetabolicaUniversità Cattolica del Sacro Cuore, Policlinico A. GemelliRomeItaly

Personalised recommendations